Jie Shi Yan, MD

Jie Shi Yan, MD has extensive work experience in the medical field. Currently, they serve as the Co-Founder & Lead Clinician at Gordy Health since December 2021. Prior to that, they worked as the Principle Investigator at CALIFORNIA KIDNEY MEDICAL GROUP INC starting from October 2021.

Before these roles, Dr. Yan held the position of Principal Investigator at California Kidney Medical Group from June 2017 to January 2019. They were also a Partner at the same company from July 2005 to June 2017.

Throughout their career, Dr. Yan has taken on various research responsibilities. They have served as a Principal Investigator for multiple studies conducted by companies such as Amgen, GlaxoSmithKline, AMAG Pharmaceuticals Inc., and Rockwell Medical Technologies, Inc. These studies focused on topics including the treatment of chronic kidney disease and the management of anemia in patients on hemodialysis.

Additionally, Dr. Yan has worked as an Investigator and Sub-Investigator for studies conducted by Genentech, Watson Laboratories, Affymax, and Roche Laboratories, among others.

Overall, Dr. Jie Shi Yan's work experience demonstrates their expertise and commitment to advancing medical research in the field of kidney health and related conditions.

Jie Shi Yan, MD began their education in 1993 at the Joan & Sanford I. Weill Medical College of Cornell University, where they pursued a Master of Science (MS) degree in Cell Biology and Genetics. They completed this degree in 1996.

Following their time at Cornell, Jie Shi Yan enrolled at McGill University from 1996 to 1998, though it is unclear whether they obtained a degree from this institution.

From 1998 to 2000, Jie Shi Yan attended the Stanford University School of Medicine, where they successfully obtained their Doctor of Medicine (M.D.) degree, specializing in Medicine.